News for 'FDA'

Ranbaxy gets USFDA nod for Atenolol tabs

Ranbaxy gets USFDA nod for Atenolol tabs

Rediff.com2 Jan 2007

Ranbaxy Pharmaceuticals Inc said on Tuesday it has received US Food and Drug Administration's approval for manufacturing and marketing cardiovascular drug -- Atenolol tablets in the US.

Biocon's insulin 'pen'

Biocon's insulin 'pen'

Rediff.com22 Apr 2005

Sun-Ranbaxy merger may spill over to 2015

Sun-Ranbaxy merger may spill over to 2015

Rediff.com15 Nov 2014

The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.

Sun Pharma recalls over 5,000 bottles of eye medicine in the US

Sun Pharma recalls over 5,000 bottles of eye medicine in the US

Rediff.com8 Mar 2015

The recall was initiated by the company on January 21

Company Watch: Emami, Shriram Transport, Lupin

Company Watch: Emami, Shriram Transport, Lupin

Rediff.com8 Feb 2021

Check out some of the stocks that will react on the basis of their numbers in the near term.

Why 1,700 employees of Pfizer's India arm may lose their jobs

Why 1,700 employees of Pfizer's India arm may lose their jobs

Rediff.com10 Jan 2019

A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.

US sees red over sindoor

US sees red over sindoor

Rediff.com19 Dec 2007

Indian women may consider it sacred to adorn 'Sindoor' (vermilion) on their foreheads, but the United States government has warned against using a particular brand of this toxic 'red powder' due to high lead content.

COVID-19 doubling rate improves to 7.5 days: Centre

COVID-19 doubling rate improves to 7.5 days: Centre

Rediff.com20 Apr 2020

In its daily briefing, the government also reported Goa is now free of coronavirus.

Glenmark, US co ink $27m deal

Glenmark, US co ink $27m deal

Rediff.com5 Jun 2006

Glenmark Pharmaceuticals Inc, has signed a $27 million royalty deal with international healthcare investment fund Paul Capital Partners' Royalty Fund to finance the development of 16 dermatological products by the pharma major for the US market.

Alembic launches Cepime

Alembic launches Cepime

Rediff.com28 Jan 2003

Alembic Ltd has launched a 4th Generation Injectable Cephalosporin Cefepime under the brand name of Cepime.

10 large caps for good returns in 2021

10 large caps for good returns in 2021

Rediff.com15 Jan 2021

Investment in market leaders with a safety-first approach could yield reasonable returns across sectors.

India's Super Rich got richer in 2017

India's Super Rich got richer in 2017

Rediff.com8 Jan 2018

Of the 23 Indian billionaires mentioned in the Bloomberg Billionaires Index, only one saw a reduction in net worth, with the companies owned by most of them outperforming the Nifty 50 index by a big margin.

SPARC shares surge 15%; m-cap up by Rs 1,685 cr

SPARC shares surge 15%; m-cap up by Rs 1,685 cr

Rediff.com9 Mar 2015

The company's market value rose by Rs 1,684.87 crore.

Ranbaxy discontinues arthritis drug

Ranbaxy discontinues arthritis drug

Rediff.com12 Apr 2005

Ranbaxy Laboratories Ltd on Tuesday said it has decided to discontinue all its 'Valdecoxib' formulations with immediate effect from Indian markets.

Pak pharma cos keen to shift from China to India

Pak pharma cos keen to shift from China to India

Rediff.com15 Sep 2005

Unhappy with Chinese machinery and raw materials they have been importing so far, Pakistani pharmaceutical companies are now longing to increase their business ties with India, and asked New Delhi to relax the "stringent visa norms".

Maharashtra chemists on strike on Jan 11, 12

Maharashtra chemists on strike on Jan 11, 12

Rediff.com10 Jan 2006

More than 44,000 chemists and druggists across Maharashtra will go on a two-day strike on January 11 and 12 to protest the 'draconian' measure by the Food and Drug Administration, which proposed withdrawal of licences in case of any violation.

US nod for 2 Indian anti-AIDS drugs

US nod for 2 Indian anti-AIDS drugs

Rediff.com22 Jun 2005

Maharashtra chemists' strike on Jan 11, 12

Maharashtra chemists' strike on Jan 11, 12

Rediff.com3 Jan 2006

More than 44,000 chemists and druggists across Maharashtra would go on a two-day strike on January 11 and 12

Cadila gets USFDA nod for Gatifloxacin

Cadila gets USFDA nod for Gatifloxacin

Rediff.com29 Nov 2005

Cadila Healthcare Ltd has received tentative approval from US FDA to market its antibiotic, Gatifloxacin tablets, 200 mg and 400 mg, in the US market.

Did Nestle India have the option to stop total Maggi recall?

Did Nestle India have the option to stop total Maggi recall?

Rediff.com10 Aug 2015

Nestle refused to regret the mistake in a public statement.

Here's Chantix, a drug that helps you quit smoking

Here's Chantix, a drug that helps you quit smoking

Rediff.com12 May 2006

Scientists have developed a new and more effective drug to help smokers quit the habit, which is known to reduce the life span of those addicted by about 10 years and is the single most important factor for heart attacks the world over.

'Insects found' in infant milk powder

'Insects found' in infant milk powder

Rediff.com31 Dec 2003

The Maharashtra Food and Drug Administration has ordered withdrawal of Amulspray from Mumbai with immediate effect.

Cadila gets USFDA approval for Levofloxacin

Cadila gets USFDA approval for Levofloxacin

Rediff.com24 Apr 2006

Cadila Healthcare Ltd on Monday said it has received tentative approval from the US FDA to market Levofloxacin tablets of 250 mg, 500 mg and 750 mg in the US market.

How safe is the baby oil?

How safe is the baby oil?

Rediff.com19 Mar 2005

Dr Reddy's: New launches to drive growth

Dr Reddy's: New launches to drive growth

Rediff.com28 Jun 2013

Analysts are eyeing bigger launches that will positively impact company's fortunes.

Ranbaxy gets nod for Fluoxetine

Ranbaxy gets nod for Fluoxetine

Rediff.com15 Dec 2004

United States' Food and Drug Administration has granted approval to Ranbaxy Laboratories Ltd to manufacture and market 40 mg capsules of Fluoxetine, a drug used in treatment of obsessive-compulsive disorders.\n\n

Ind-Swift's $15 m GDR by June-end

Ind-Swift's $15 m GDR by June-end

Rediff.com10 Jun 2005

US regulator urges USV to probe staff for inaccurate data reporting

US regulator urges USV to probe staff for inaccurate data reporting

Rediff.com5 Mar 2014

The US Food and Drug Administration has asked USV to probe employees who might have been responsible for inaccurate data reporting.

Hair oil cos asked to label contents

Hair oil cos asked to label contents

Rediff.com11 Jun 2005

Glenmark gets USFDA nod for drug

Glenmark gets USFDA nod for drug

Rediff.com19 Jun 2013

Riluzole is indicated for the treatment of amyotrophic lateral sclerosis.

Nagpur man finds worms in medicines

Nagpur man finds worms in medicines

Rediff.com15 Oct 2003

The worms were detected in Elferri capsules, manufactured by a Goan company. The FDA has initiated a probe.

Worms found in chocolate packet

Worms found in chocolate packet

Rediff.com3 Oct 2003

Sandoz opens third plant in India

Sandoz opens third plant in India

Rediff.com19 May 2004

Global generic drugs producer Sandoz has opened its third plant in India at Navi Mumbai with annual production capacity of one billion tablets and capsules.

Ants in mineral water; Mumbai plant shut

Ants in mineral water; Mumbai plant shut

Rediff.com12 Sep 2003

The presence of ants was detected at Alibag in Maharashtra and subsequently a complaint was lodged with the Food and Drug Administration authorities.

Singh brothers count on disclosure to counter Daiichi claims

Singh brothers count on disclosure to counter Daiichi claims

Rediff.com18 Nov 2013

Facing arbitration claims by Daiichi Sankyo, Ranbaxy's former Indian promoters - Malvinder Mohan Singh, his brother Shivinder Mohan Singh and family - are counting on certain clauses in the share purchase agreement (SPA) signed with the Japanese company on June 11, 2008, to claim immunity from damages.

J&J gets reprieve on baby oil

J&J gets reprieve on baby oil

Rediff.com6 May 2005

Ranbaxy gets USFDA nod for Ofloxacin

Ranbaxy gets USFDA nod for Ofloxacin

Rediff.com20 Jun 2003

Ranbaxy Laboratories on Friday said it has received tentative approval from US Food and Drug Administration to manufacture and market Ofloxacin, the generic version of Ortho Mcneil Pharmaceutical Inc's Floxin.